Please enable JS

News

20 06

The medical aesthetic market in Asia is growing faster than in any other region and for this reason IMCAS Asia is becoming the ideal platform for aesthetic industry players to present their latest innovations to this expanding area.

The 2017 edition of this congress will take place from 21st to 23rd of July in the idyllic island of Bali at Bali International Convention Centre (The Westin Resort – Nusa Dua).

Neauvia will be present at this strategic appointment - together with the local distributor PT Regenesis - at booth 49 where it will be possible to discover its complete range of fillers and cosmeceuticals and be informed on the latest products and developments.

Moreover, an appointment not to be missed will be the workshop: “Neauvia Aesthetic Global corrections: the state of art” that will take place in Room 4A, Saturday the 22nd of July from 14.40 to 15.00.

In this occasion, with a live injection demonstration, will be held a session relating to safety and efficacy of NEAUVIA range, the new 2nd generation of HA fillers.

13 06

In presence of a very interested and enthusiastic international audience, the first Neauvia K.O.L. advanced training course hosted in Pavia (Italy) at the CMP, Centro Medico Polispecialistico.

The event focused on real-time training of physicians and included a question and answer session. It was held by an impressive panel of 14 speakers: Dr. Nicola Zerbinati, Dr. Damiano Monticelli, Dr. Giovanna Cipolla, Professor Alberto Calligaro, Roberto Mocchi, Professor Alberto Passi, Dr. Marina Protasoni, Dr. Mario Cherubino, Dr. Gabriele Fornasari, Dr. Edoardo D’Este, Dr. Laura Balint and Dr. Mauro Castiglioni.

Some of the main topics discussed were chemical evidences, chemical pharmacological aspects, histologic and biochemical aspects. More than 40 doctors and 10 distributor, coming from all over the world, attended this interactive course with great interest and participation. It was the perfect occasion to study and intensively discuss both Neauvia fillers and cosmeceuticals.

This training session of Academy Neauvia - dedicated to enhancing the knowledge, skills and expertise of the physicians who choose Neauvia products for their patients - was organized by the Scientific Institute Neauvia, created to gather several well-known specialists from different nations and that is involved in the scientific information and research of the aesthetic medicine field.

25 05

Being aware of the differences between men and women tissue as well as their subjective expectation from the aesthetic medicine, Neauvia developed a unique man line of bioactive fillers and mesotherapy products, which help to reduce the signs of passing years and keep the young, energetic appearance.

INTENSE MAN

A specific formula with the highest concentration of HA (28mg/ml) and high viscoelasticity that suits perfectly for thicker skin and more rapid process of aging. Intense Man can be used to add volume in the sagging area and to fill the folds and deep wrinkles.

Discover more

STIMULATE MAN

Stimulate Man is the first filler dedicated to help fighting the time in two ways: 28 mg/ml of hyaluronic acid and high viscoelasticity of the hydrogel fill tissue deficits for a long time. The addition of 1% of calcium hydroxyapatite gives extra stimulation effect by activating fibroblasts to collagen stimulation.

Discover more

HYDRO DELUXE MAN

Mesotherapy is one of the most popular aesthetic treatments that significantly improve quality of the skin. The aim of it is to deliver active substances directly to the skin and to give an immediate hydration.Neauvia Organic Hydro Deluxe Man contains 18 mg/ml of pure hyaluronic acid derived from Bacillus subtilis. Such high concentration allows to obtain very good results noticeable from the first treatment.

Discover more

09 05

6th May 2017: During the IXth edition of the "International Congress of Anti-Aging Medicine” held in Bucharest - and known as the main scientific landmark in Romania – Neauvia was awarded with the "Newest Dermal Filler" Trophy.

The Anti-Aging Trophy is organized during this important congress to reward the best and most important achievements of the companies operating in the field and it judges, in ten different categories, aesthetic products and treatments.

It’s With a great honor we announce that, for the edition 2017, the scientific committee of the Romanian Anti-Aging Association chose to reward Neauvia with the "Newest Dermal Filler” prize: an amazing result that encourages us to keep working hard in order to bring to market something even more unique!

05 05

Talking about Neauvia in the latest issue of Anti-Age magazine. The first magazine about anti aging and aesthetic medicine interviews Dr Nicola Zerbinati, professor of Dermatology and Venereology at the University of Insubria (Italy), scientific Coordinator of the International Academy of Cosmetic Gynecology IACG. The subject matter? The new technology behind Neauvia HA fillers.

Here follows the complete interview:

Dr. Zerbinati: NEAUVIA ORGANIC is a new generation of fillers with pure hyaluronic acid, derived from Bacillus Subtilis - a probiotic and non-pathogenic bacterial strain - and a new cross-linking agent, conferring outstanding properties to the hydrogel: PEG-polymer (Polyethylen-glycol). PEG bonds the molecules of hyaluronic acid with a high degree of interpenetration, achieving a more cohesive, visco-elastic and easily moldable filler, which adapts to the structure of the tissues, while longer maintaining the desired shape. The advantages are considerable: fillers have slow biodegradation, do not migrate and ensure natural results and a lower risk of immunomediate reaction

Why did Neauvia decide to use the polymer PEG as crosslinker instead of the common BDDE molecule used by all the other companies? 

Dr. Zerbinati: Hyaluronic acid fillers are used in the practice of aesthetic medicine as the gold standard procedure for both the correction of wrinkles and the restoration of volumes, thanks to the technological evolution achieved over the years. 

Crosslinked agents underwent an evolution, as well, trying to use progressively less toxic chemical substances. Crosslinking with Polyethylene Glycol, known in pharmacology as PEGylation, seems to offer considerable advantages also in the field of fillers for aesthetic medicine use in terms of both safety and gel performances. 

As regards safety, along with a lower toxicity (30 times less than BDDE), PEG has the peculiar and extremely interesting characteristic of hiding the substance to which it is bound, from the host immune system, with consequent reduction of immunogenicity and antigenicity. 

From a clinical point of view, biomimetic properties – allowing a physiologic integration of the gel into the host tissue and the high biomechanical compatibility of the new hydrogel matrix with a large meshes structure, which are interpenetrated and non-static – offer a higher yield in terms of aesthetic correction, the quantity being equal compared to other fillers, as well as a higher heat and mechanical stress resistance, thereby extending the half-life of the HA filler. 

What are the rheological and structural properties of Neauvia hydrogel with PEG? 

Dr. Zerbinati: Both PEG and hyaluronic acid are polymers and their union allows creating matrices with a scaffold architecture that is a three-dimensional network consisting of interpenetrating large meshes: they both offer a better integration of the gel into the tissues and the possibility of including and gradually releasing molecules, which are useful for skin rejuvenation

Another interesting aspect concerns the gel’s rheological properties and cohesiveness; the proper balance between viscosity-elasticity and plasticity, as well as the degree of cohesiveness, allows a perfect dermal integration without risks of visibility/palpability or dislocation of the implant. Pegylation, as already stated before, allows for the creation of three-dimensional interpenetrated matrices; however, it should be underlined that this dynamic structure, highly resistant to mechanical stress and heat, thanks to the longer distances among the HA chains induced by the use of PEG polymer, allows not only to adapt to various tissue densities, but also to reduce the risks of foreign body giant cell formation. 

Why Neauvia uses a low percentage and a small molecular size of calcium hydroxyapatite in the filler called Stimulate?

Dr. Zerbinati: Although calcium hydroxyapatite does not represent an innovation in the field of dermal fillers, the difference with the already existing formulations is substantial for the choice of both dimensions and quantity of the microsphere used. 

As regards the size, clinical studies have shown that, in presence of microspheres with size of less than 20 micron, the cellular response involves a significantly higher number of cells than larger microspheres (40- 80 / 80-200 micron). Even macrophage activation has proved to be relatively higher compared to microspheres of intermediate or bigger size, whereas it has been highlighted, a lower percentage of giant cells compared to those with microsphere of intermediate or bigger size. Calcium hydroxyapatite microspheres, included into the matrix of the HA filler are gradually released and, due to their size and quantity, they are not encapsulated but, during their degradation, they promote a soft inflammatory response, which results in a prolonged cellular stimulation. Therefore, the hydrated matrix, with scaffold architecture, of the hyaluronic acid gel becomes extremely interesting, since it represents the ideal environment for the fibroblastic activity

What kind of scientific evidence has Neauvia got on the collagen production quantity and quality after injection with Stimulate? 

Dr. Zerbinati: Investigations carried out at the Neauvia Research Centre and presented during some International congresses have highlighted how the formulation promotes the fibroblastic stimulation and a real regeneration of the dermal collagen. 

Observations conducted with an electron micrograph on dermal fibroblasts have highlighted specific ultrastructural aspects strictly connected with their functional stimulation oriented towards the renewal of the constituent collagen of the matrix, contributing also to the plumping action of tissue. 

Further observations, made with circularly polarised microscope on preparations coloured with Picrosirius Red, allowed identifying numerous sites of formation of new collagen in the connective matrix. 

In conclusion, it can be stated the inoculation of the filler is associated with a fibroblast stimulation that produce new matrix, mainly consisting of collagen and amorphous matrix, which represents a synergic action with the plumping action of the filler for a more effective distention of the skin. The formulation containing calcium hydroxyapatite, Stimulate, clinically offers the opportunity to correct deep imperfections or to increase face volumes, improving, at the same time, skin quality and density.

Download full article

26 04

From the 5th to the 7th of May 2017, Neauvia will be present at the "International Congress of Anti-Aging Medicine” in Buchrest (Romania). 

This important congress - this year at its IXth Edition - is the main scientific landmark in Romania and it offers numerous live workshops aiming at preparing doctors to a new approach to anti-aging treatments and at strengthening the doctor-patient relationship.

Neauvia, together with the local distributor Mezo Factor Srl, will attend for the first time this important event with its booth in Central Exhibitors Hall, Stand n° 8, officially presenting its fillers and cosmeceutical lines to the market.

In addition, two interesting workshops will be held by Professor Nicola Zerbinati on the 6th of May, at the hall New York Auditorium:

from 12.10 to 13.00:  "New 2nd generation of Hyaluronic Acid dermal fillers NEAUVIA ORGANIC"
and 
from 16.10 to 17.00:  "Modern and non-invasive treatment PLASMA IQ”.

A rich calendar of appointments not to be missed!

14 04

We would like to thank all the guests who visited us at AMWC 2017.
The 15th Edition of Aesthetic & Anti-aging Medicine Congress, has been an occasion for Neauvia to introduce the last important news and strengthen the fundamental relationships with its partners: distributors and doctors coming from all over the world.

The big affluence to the “Neauvia Aesthetic Global Corrections: the state of art” held by professor Zerbinati - together with Professors Alberto Calligaro, Alberto Passi e Pier Camillo Parodi - has been also a source of pride and a demonstration of the strong interest aroused internationally by Neauvia.

Our next appointments will be:

  • INTERNATIONAL CONGRESS OF ANTI-AGING MEDICINE - Bucharest (Romania) 5, 6 and 7th of May 2017
  • IMCAS ASIA - Bali (Indonesia) 21, 22 and 23rd of July 2017 -
  • VISAGE – Monte Carlo (Monaco) 15, 16 and 17th of September 2017

We look forward to seeing you there!

24 03

From the 27th to the 29th of March NEAUVIA is going to exhibit at the Dubai Derma: a unique event held annually at the Dubai International Convention and Exhibition Centre, UAE that is dedicated to practitioners, specialists, manufacturers and distributors in the field of dermatology, skin care and laser.

The Dubai World Dermatology & Laser Conference & Exhibition became a pioneer event in the Gulf & the MENASA region that showcases the best practices in dermatology science and the latest technology in skin care through specialized exhibition, lectures, courses and workshops.

NEAUVIA will take part at this important appointment together with the local distributor Life Style Aesthetics.

Come and visit us at Booth 6E08 in Venue Dubai World Trade Center, where it will be possible to discover Neauvia range and be informed on the latest products and developments.

21 03

For another year NEAUVIA will be present at the annual congress AWMC in Monte Carlo
The 15th edition of Aesthetic & Anti-aging Medicine World Congress, the world's largest event for Global Aging Management, will take place from the 6th to the 8th of April.

Over the last 15 years AMWC has played a key role in underpinning the scientific understanding of global anti-aging management, attracting, every year, about 10.000 participants coming from more than 120 countries.

AMWC 2017 will showcase cutting edge presentations by some of the most sought after experts in the fields of Aesthetic Dermatology, Plastic & Aesthetic Surgery and multidisciplinary Preventive & Anti-Aging Medicine.

NEAUVIA will take part in this important event at BOOTH N2 in RAVEL ROOM, situated on the 1st floor of the Grimaldi Forum, where it will be possible to be informed on the latest products and developments.

Moreover the WORKSHOP “Neauvia Aesthetic Global Corrections: the state of art” will be held on the 6th of April, from 3pm to 4pm in Room Genevoix by Professor Nicola Zerbinati, together with Prof. Alberto Calligaro, Prof. Alberto Passi and Prof. Pier Camillo Parodi.

An EXCLUSIVE GIFT will be given to the first 100 workshop participants.

Download invitation.

06 02

We are delighted and honoured to announce that Neauvia Hydro Deluxe won prestigious AWARD from the Polish Society of Aesthetic Dermatologists, a PEARL of Aesthetic Dermatology in category of Best Mesotherapy Product

Mesotherapy is one of the most popular aesthetic treatments that significantly improve quality of the skin. Hydro Deluxe is a soft treatment for face and body with hyaluronic acid. In 4 to 5 sessions, the synergy of HA with aminoacids and CaHA is able to make skin glowing with a redensification of the tissues and collagen production. Hydro Deluxe is ideal for bio-revitalization of delicate areas around the eyes and neck and for hands rejuvenation. 

It's always a great validation to win an award and we are very grateful for the support we got both from the Polish Society of Aesthetic Dermatologists, that named Hydro Deluxe for the 2016 award edition, and our Customers, who believe in our brand and daily use Neauvia products. Winning this award was a great boost on keeping us focused on our future projects to bring on market something even more unique!

  Previous page  1  2  3  Next page  

Matexlab


Via Maggio 1C | CH-6900 Lugano | CHE422592120 Switzerland

© 2017 Matex Lab SA. All rights reserved

This website uses cookies. Please be informed that the continuation of the navigation through access to another area of the site or selecting an item will mean the provision of consent to the use of cookies.